摘要
目的:探讨奥扎格雷钠联合依达拉奉治疗急性脑梗死的临床疗效。方法:80例急性脑梗死患者随机分为治疗组和对照组,每组40例患者,在常规内科治疗的基础上,对照组单用奥扎格雷钠、治疗组给予奥扎格雷钠联合依达拉奉治疗。观察两组患者的临床疗效、神经功能缺损评分和血液流变学指标。结果:治疗组的有效率显著高于对照组,且无明显不良反应(P<0.05);与对照组比较,治疗组治疗后的神经功能缺损评分明显改善(P<0.05),且不影响血液流变学指标。结论:奥扎格雷钠联合依达拉奉治疗急性脑梗死疗效好,不良反应少。
Objective：To investigate the effects of sodium ozagrel combined edamvone in treatment of acute cerebral infarction.Methods：80 acute cerebral infarction patients were randomly divided into 2 groups with 40 patients in each group. Besides conventional medical treatment, the patients in control group received sodium ozagrel only, the patients in treatment group received sodium ozagrel combined edamvone. The clinical effects, neurologic severity scores and hemorheology parameters of patients in these 2 groups were compared.Results： The clinical effects of treatment group was obviously higher than control group and no obvious adverse reactions （P〈 0.05）. Compared with control group, the neurologic severity scores of patients in treamaent group improved obviously （P〈 0.05）. And sodium ozagrel combined edaravone didn＇t affect hemorheology parameters.Conclusions： Treating acute cerebral infarction with sodium ozagrel combined edaravone can get better clinical effects and fewer adverse reactions.
出处
《承德医学院学报》
2013年第6期468-470,共3页
Journal of Chengde Medical University
关键词
脑梗死
奥扎格雷钠
依达拉奉
疗效
Cerebral infarction
Sodium ozagrel
Edaravone
Clinical effects
